Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Publisher Correction: Multimodal cell maps as a foundation for structural and functional genomics.
Journal: Nature
Published: October 02, 2025
Fibroblast growth factor receptor alterations and resistance mechanisms in the treatment of pediatric solid tumors.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: December 16, 2024
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: August 16, 2024
Multimodal cell maps as a foundation for structural and functional genomics.
Journal: Nature
Published: June 03, 2024
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 26, 2023
USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation.
Journal: International journal of molecular sciences
Published: June 30, 2023
UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis.
Journal: Cell death & disease
Published: January 30, 2023
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
Journal: International journal of cancer
Published: December 16, 2022
Identification of a novel gene signature for neuroblastoma differentiation using a Boolean implication network.
Journal: Genes, chromosomes & cancer
Published: April 01, 2022
Overview and recent advances in the targeting of medulloblastoma cancer stem cells.
Journal: Expert review of anticancer therapy
Published: May 28, 2021
Last Updated: 09/26/2026